FIELD: chemistry.
SUBSTANCE: invention concerns biologically active compounds with inhibition effect on binding antigen with II class MHC molecules, particularly with II class MHC molecule HLA-DR2. Also, the invention proposes pharmaceutical compositions containing such compounds, and their application in obtaining medications for treatment or prevention of diseases connected to T-cell proliferation, such as autoimmune diseases and disorders of inhibition of binding II class MHC molecule HLA-DR2.
EFFECT: obtaining pharmaceutical composition for treatment or prevention of diseases connected with T-cell proliferation.
17 cl, 4 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CONDENSED PYRROLO[2,3-C]CARBAZOL-6-ONES THAT ENHANCE ACTIVITY OF GAMMA-INTERFERON | 1997 |
|
RU2193037C2 |
| 5'-CAP-TRINUCLEOTIDE COMPOUNDS OR 5'-CAP COMPOUNDS WITH LARGE NUMBER OF NUCLEOTIDES AND THEIR USE FOR RNA STABILIZATION, PROTEIN EXPRESSION AND IN THERAPY | 2019 |
|
RU2811940C2 |
| HYDANTOIN MODIFIED MELANOCORTIN RECEPTOR LIGANDS | 2008 |
|
RU2450017C2 |
| RECOMBINANT pMHC MOLECULES OF CLASS II | 2017 |
|
RU2777115C2 |
| CONJUGATES OF BINDER (ADC) WITH KSP INHIBITORS | 2014 |
|
RU2698697C2 |
| OXYSTEROLS AND THEIR APPLICATION METHODS | 2017 |
|
RU2754130C2 |
| GENETICALLY MODIFIED ANIMALS OTHER THAN HUMANS FOR PRODUCING THERAPEUTIC ANTIBODIES AGAINST PEPTIDE-MHC COMPLEXES, METHODS FOR PRODUCTION AND VERSIONS OF USE THEREOF | 2019 |
|
RU2819525C2 |
| NEUROACTIVE COMPOUNDS AND THEIR APPLICATION METHODS | 2015 |
|
RU2764702C2 |
| CYANOTHIENOTRIAZOLODIAZEPINES AND METHODS FOR THEIR USE | 2016 |
|
RU2750164C2 |
| OXYSTEROLES AND METHODS OF USING THEM | 2016 |
|
RU2744267C2 |
